News | Computer-Aided Detection Software | November 26, 2018

Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018

Company will display AI-based software for analysis of cardiac MRI, liver, lung and mammography imaging

Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018

November 26, 2018 — Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-powered solutions that support fast, efficient and accurate analysis of medical images at the 2018 Radiological Society of North America (RSNA 2018) annual meeting, Nov. 25-30 in Chicago.

Driven by deep learning and cloud computation, the Arterys platform uses the power of the internet to enhance clinician workflow, streamlining and speeding analysis of breast, heart, liver and lung images to deliver improved patient outcomes for key workflows.

Arterys will provide demonstrations of its AI-powered, web-based solutions, including:

  • Arterys Cardio AIMR combines deep learning and cloud computing to automate analysis of cardiac magnetic resonance (MR) images. By eliminating many tedious, manual tasks, Arterys Cardio AI enables clinicians to quickly and easily identify, determine treatment for and track heart problems. It is the first and only commercial solution, according to the company, to offer deep learning-based semi-quantitative perfusion and quantitative delayed enhancement analysis*.
  • Arterys Liver AI is used to efficiently measure and track liver lesions. It enables visualization and longitudinal tracking, and faster volumetric segmentation with integrated Liver Imaging Reporting and Data System (LI-RADS) workflow. The Arterys Liver AI user-friendly interface and seamless workflow supports greater measurement accuracy, and enables clinicians to make a more objective and confident treatment decision.
  • Arterys Lung AI provides improved tracking of lung nodules to aid in clinical management. The solution's volumetric segmentation yields more accurate measurements, while automated longitudinal tracking helps clinicians better manage nodule progression. Arterys Lung AI includes a dedicated Lung-RADS scoring panel for screening examinations, which captures key features and calculates scores. Automatic reporting capabilities deliver summaries of findings and can be customized to display relevant quantitative information, images and comments. Lung AI also offers detection capabilities, which are available clinically in the European Union and for research only in the United States.
  • Arterys Viewer is powered by AI to increase speed, efficiency and accuracy of reading medical images. Offering multimodal support, including for MRI, computed tomography (CT), X-ray and ultrasound images, Arterys Viewer is designed to deliver the best patient outcome by enabling clinicians to share images, collaborate and consult via a shared workspace.
  • Arterys Breast AI for Mammography supports viewing mammograms using the Google Chrome web browser. The Arterys Breast AI solution enables providers to easily and intelligently recognize higher priority cases, effectively allocate time for reviewing cases, and facilitate more informed decisions on the review priority and timing of screening studies. The solution automatically generates graphical bounding boxes to identify regions of interest on an image, serving as a mammography assistant that enables clinicians to focus on suspicious areas before, during or after diagnosis. Breast AI for Mammography is currently for research use only and not for use in any diagnostic procedures.

The Arterys HIPAA- and EU GDPR-compliant solutions integrate with existing electronic health records (EHRs), picture archiving and communication system (PACS), and  radiology information system (RIS) environments and dictation solutions.

For more information: www.arterys.com

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Videos | Computed Tomography (CT) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radio
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...